Fish oil supplements shouldn’t be considered equivalent to omega-3 products that have undergone strict clinical testing and FDA oversight, said biochemist Preston Mason, PhD. The first group of products could be harmful to patients with cardiovascular disease, while more refined compounds might help.

People are more likely to prefer a daily cup of tea or a pill over exercise as a treatment options for high blood pressure, according to findings of a survey presented April 7 at the American Heart Association’s Quality of Care and Outcomes Research Scientific Sessions 2018 in Arlington, Virginia.

Hypertension, elevated cholesterol and hearing difficulty are more prevalent among noise‐exposed workers, according to new research led by the Centers for Disease Control and Prevention (CDC)’s National Institute for Occupational Safety and Health (NIOSH).

Though many areas of the world are seeing an increase in childhood obesity rates, Amsterdam has cut the number of overweight and obese children by 12 percent through city-wide “healthy-weight program" that has kids weighed regularly and tested for balance and agility.

Both men and women over the age of 50 have reduced their risk factors for heart disease and stroke over a 20-year period, according to a new study published online March 22 in Aging Clinical and Experimental Research.

Individuals who consume large amounts of meat protein experience a 60 percent increase in cardiovascular disease (CVD), according to research published in the International Journal of Epidemiology on April 3.

The YMCA and American Heart Association (AHA) are launching a collaborative effort this spring to help combat hypertension. Through the new partnership, clinics participating in the AHA and American Medical Association’s national Target: BP initiative can refer patients to the YMCA for free support in learning how to self-monitor their blood pressure.

The Dexcom G6 continuous glucose monitoring (CGM) system received FDA marketing approval March 27, the agency announced. This is the first system permitted by the FDA to be used in an “integrated” fashion alongside other diabetes management devices, including automatic insulin dosing systems, insulin pumps and blood glucose meters.